Project Grant R03DA064467
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$335K
Federal Agency
National Institute on Drug Abuse
Awardee
Emory University (S352L5PJLMP8)
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
This Project Grant award, totaling $1,481,760 and provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate how methamphetamine (MA) use promotes immune dysfunction in people living with HIV (PWH) even during antiretroviral therapy (ART) suppression. The research aims to determine how MA-induced activation of the NLRP3 inflammasome leads to altered metabolism, epigenetics, and immune dysfunction in T...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,940,518 to Wake Forest University Health Sciences (WFUHS) to conduct a mechanistic clinical trial investigating the neuroimmune pathways linking chronic psychosocial stress to co-occurring stimulant use and depression in people living with HIV (PWH). The study aims to: 1) investigate the causal link between a positive affect intervention...
This federal Project Grant award for $263,119 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is focused on developing NLRP3 inhibitors to address HIV-associated neuroinflammation in cocaine use. The key objectives are to computationally design, synthesize, and screen novel analogues of a lead compound, AMS-17, to improve its biological activity and maintain low toxicity. The project involves in vitro and in vivo screening of...
The National Institute on Drug Abuse (NIDA) awarded a $2,223,769 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of California, San Diego (UCSD) to investigate the individual and combined impact of HIV and opioids on inflammasome-mediated neuroinflammation and neurotoxicity. The 5-year study, which commenced on April 15, 2025, aims to uncover the mechanistic intersection between HIV and opioids that leads to more severe neurological...
The National Institute on Drug Abuse (NIDA) awarded a $1,932,699 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Maryland, Baltimore. The grant, effective August 1, 2024 through May 31, 2025, will fund a randomized trial to evaluate the effectiveness and implementation of a peer-delivered behavioral activation and problem-solving intervention, "Peer Activate-LAI," for improving adherence to long-acting injectable (LAI) HIV...
This $196,350 Project Grant was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to Yale University. The grant will fund a project titled "HIV COMPLEX CAUSAL MODELING: GUT MICROBIOME, DRUG USE, AND IMMUNE RESPONSES" from August 1, 2024 to July 31, 2026. The project aims to elucidate the causal relationship between drug use disorders, HIV acquisition, gut microbiome, and immune responses using Mendelian randomization...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $157,568 to Drexel University to elucidate corticolimbic circuit and neuroimmune mechanisms underlying HIV-induced dysregulation of reward-seeking behavior. The research aims to use optogenetic and chemogenetic techniques to stimulate the infralimbic cortex-nucleus accumbens shell circuit and modulate microglial function to rescue HIV-induced...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support research to spatially characterize HIV-host cellular interactions in the central nervous system (CNS) of people with HIV (PWH) who died suddenly. The $983,672 award will fund the development and implementation of innovative single-cell and spatial genomic assays to analyze the localization, distribution, and activity of HIV-infected...
This Project Grant award, valued at $695,250.00 and awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the role of endothelial injury and myeloid cell migration in the activation of inflammasomes in HIV infection and cocaine exposure. The key objectives are to characterize myeloid cell populations in the brains of HIV-transgenic mice under chronic cocaine treatment, and evaluate the...
The National Institute on Drug Abuse (NIDA) awarded a $873,784 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Arizona State University to develop and pilot-test "Project Vuselela", an intervention integrating peer navigation and family engagement to improve antiretroviral therapy (ART) adherence and opioid substitution therapy (OST) continuation among people who inject drugs in South Africa. The project aims to assemble evidence-based practices,...